Niramaya PathLabs Competitors and Similar CompaniesClear all

Niramaya PathLabs's competitors and similar companies include Acton Medical Associates, Silence Therapeutics, Abingdon Health and Angle.

	Niramaya PathLabs Niramaya PathLabs (also known as Niramaya Healthcare) is a company providing pathology and preventative healthcare services.	Acton Medical Associates Acton Medical Associates is a clinic that provides health care solutions.	Silence Therapeutics Silence Therapeutics is a therapeutics company that develops novel, proprietary short-interfering RNA.	Abingdon Health Abingdon Health is a specialist medical diagnostics company that acquires, develops and distributes diagnostic tools and services.	Angle ANGLE plc is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health.
Founding Date	Founding Date 2013	Founding Date 1955	Founding Date 1999	Founding Date 2008	Founding Date 1994
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics
Locations	Locations New Delhi, IN HQ New Delhi, IN	Locations Acton, US HQ	Locations London, GB HQ Berlin, DE London, GB Hoboken, US New York, US	Locations North Yorkshire, GB HQ	Locations Guildford, GB HQ Toronto, CA London, GB Reading, GB King Of Prussia, US Plymouth Meeting, US
Employees	Employees 176% increase	Employees 164	Employees 6589% decrease	Employees 79	Employees 150
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 669.8 m	Valuation ($) N/A	Valuation ($) 35.9 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $559k (FY, 2025)	Revenue (est.) £2.3m (FY, 2018)	Revenue (est.) £2.9m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods $215k (FY, 2025)	Cost of goods £583.1k (FY, 2018)	Cost of goods £1.1m (FY, 2024)
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit $344k (FY, 2025)	Gross profit £1.7m (FY, 2018)	Gross profit £1.8m (FY, 2024)
Net income	Net income N/A	Net income N/A	Net income ($88.6m) (FY, 2025)	Net income £3.5m (FY, 2018)	Net income (£14.2m) (FY, 2024)
Funding
Latest funding round	Latest funding round $ 150k (about 11 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 4.8m (almost 11 years ago)	Latest funding round N/A